This list is an analysis based on recent market events. It's not an investment recommendation.
Headquartered in Kelowna, Canada, MYND Life Sciences Inc. operates as a neuro-pharmaceutical enterprise focused on creating innovative therapies for depressive disorders. The company conducts scientific research and clinical trials across Canada and the United States to develop drugs derived from neuro-anti-inflammatory compounds. A significant part of their work involves the study and development of psilocin and psilocybin extracts, as well as their synthetic analogs.
FAQs
What is MYND Life Sciences stock price today?▼
The current price of MYND.CN is C$0.07 CAD — it has increased by +0% in the past 24 hours. Watch MYND Life Sciences stock price performance more closely on the chart.
What is MYND Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Canadian Securities Exchange exchange MYND Life Sciences stocks are traded under the ticker MYND.CN.
What is MYND Life Sciences market cap?▼
Today MYND Life Sciences has the market capitalization of 3.35M
What is MYND Life Sciences revenue for the last year?▼
MYND Life Sciences revenue for the last year amounts to 0 CAD.
What is MYND Life Sciences net income for the last year?▼
MYND.CN net income for the last year is -1.52M CAD.
In which sector is MYND Life Sciences located?▼
MYND Life Sciences operates in the Health & Wellness sector.
When did MYND Life Sciences complete a stock split?▼
MYND Life Sciences has not had any recent stock splits.
Where is MYND Life Sciences headquartered?▼
MYND Life Sciences is headquartered in Port Coquitlam, Canada.